A rare case of pancreatic mixed acinar-neuroendocrine carcinoma

Pancreatic mixed acinar-neuroendocrine carcinoma (pMANEC) is an extremely rare malignancy with both acinar carcinomas with neuroendocrine lineage differentiations. Herein, we present a case of pMANEC in a 78-year-old male who initially presented to the clinic for night sweats, easy bruising, and lumbar pain, leading to the discovery of a pancreatic mass on imaging. Pathological examinations, including immunohistochemistry, confirmed the diagnosis of possible pMANEC, characterized by acinar and neuroendocrine differentiation. Further diagnostic workup with DOTATATE NM positron emission tomography/computed tomography (PET/CT) scan provided additional insights, confirming the neuroendocrine nature of the tumor. The patient was started on gemcitabine and nab-paclitaxel every other week and also started on lanreotide for treatment. Our case highlights the challenges in diagnosing and managing this rare entity and underscores the need for further research to explore its clinical behavior, molecular characteristics, and optimal therapeutic strategies. Additionally, the potential role of genetic profiling and immunotherapy in improving outcomes for patients with pMANEC warrants investigation.

Authors

Institutions

Publication Details

Journal
Journal of Case Reports and Images in Oncology
Published
2024-12-19
DOI
https://doi.org/10.5348/100138z10zk2024cr
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A rare case of pancreatic mixed acinar-neuroendocrine carcinoma

Mark Hendrixson, Kehua Zhou, Aniqa Faraz Crossville
Journal of Case Reports and Images in Oncology
Neuroendocrine Tumor Research Advances
article

A rare case of pancreatic mixed acinar-neuroendocrine carcinoma

Mark Hendrixson, Kehua Zhou, Aniqa Faraz Crossville
article en

Abstract

Pancreatic mixed acinar-neuroendocrine carcinoma (pMANEC) is an extremely rare malignancy with both acinar carcinomas with neuroendocrine lineage differentiations. Herein, we present a case of pMANEC in a 78-year-old male who initially presented to the clinic for night sweats, easy bruising, and lumbar pain, leading to the discovery of a pancreatic mass on imaging. Pathological examinations, including immunohistochemistry, confirmed the diagnosis of possible pMANEC, characterized by acinar and neuroendocrine differentiation. Further diagnostic workup with DOTATATE NM positron emission tomography/computed tomography (PET/CT) scan provided additional insights, confirming the neuroendocrine nature of the tumor. The patient was started on gemcitabine and nab-paclitaxel every other week and also started on lanreotide for treatment. Our case highlights the challenges in diagnosing and managing this rare entity and underscores the need for further research to explore its clinical behavior, molecular characteristics, and optimal therapeutic strategies. Additionally, the potential role of genetic profiling and immunotherapy in improving outcomes for patients with pMANEC warrants investigation.

Journal of Case Reports and Images in OncologyVol. 10(2)
Theda Clark Medical Center (US), Cumberland Medical Center (US)
Good health and well-being
Openalex Percentile: Top 65%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.